B
BOTANIX PHARMACEUTICALS LTD
ASX: BOT (BOTANIX FPO [BOT])
Last update: 2 days ago, 11:55PM0.450
0.00 (0.00%)
| Previous Close | 0.450 |
| Open | 0.445 |
| Volume | 3,388,708 |
| Avg. Volume (3M) | 5,035,255 |
| Market Cap | 817,933,440 |
| Price / Sales | 1,122.19 |
| Price / Book | 7.49 |
| 52 Weeks Range | |
| Earnings Date | 26 Feb 2025 - 3 Mar 2025 |
| Operating Margin (TTM) | -500.47% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | 2,753.20% |
| Current Ratio (MRQ) | 22.21 |
| Operating Cash Flow (TTM) | -8.13 M |
| Levered Free Cash Flow (TTM) | -20.30 M |
| Return on Assets (TTM) | -12.74% |
| Return on Equity (TTM) | -21.07% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (AU) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | BOTANIX FPO [BOT] | - | - |
AIStockmoo Score
1.5
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 1.50 |
|
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 12.64% |
| % Held by Institutions | 13.75% |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |